These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38822593)

  • 1. Amiloride versus furosemide for the treatment of edema in patients with nephrotic syndrome: A pilot study (AMILOR).
    Schork A; Vogel E; Bohnert BN; Essigke D; Wörn M; Fischer I; Heyne N; Birkenfeld AL; Artunc F
    Acta Physiol (Oxf); 2024 Aug; 240(8):e14183. PubMed ID: 38822593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride resolves resistant edema and hypertension in a patient with nephrotic syndrome; a case report.
    Hinrichs GR; Mortensen LA; Jensen BL; Bistrup C
    Physiol Rep; 2018 Jun; 6(12):e13743. PubMed ID: 29939487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome.
    Frățilă G; Sorohan BM; Achim C; Andronesi A; Obrișcă B; Lupușoru G; Zilișteanu D; Jurubiță R; Bobeică R; Bălănică S; Micu G; Mocanu V; Ismail G
    J Clin Med; 2023 Nov; 12(21):. PubMed ID: 37959360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity.
    Kamenicky P; Blanchard A; Frank M; Salenave S; Letierce A; Azizi M; Lombès M; Chanson P
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2127-35. PubMed ID: 21508131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial.
    Fallahzadeh MA; Dormanesh B; Fallahzadeh MK; Roozbeh J; Fallahzadeh MH; Sagheb MM
    Am J Kidney Dis; 2017 Mar; 69(3):420-427. PubMed ID: 28043731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of albumin-furosemide in patients with the nephrotic syndrome.
    Ghafari A; Mehdizadeh A; Alavi-Darazam I; Rahimi E; Kargar C; Sepehrvand N
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):471-5. PubMed ID: 21566302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on edema in childhood nephrotic syndrome.
    Teoh CW; Robinson LA; Noone D
    Am J Physiol Renal Physiol; 2015 Oct; 309(7):F575-82. PubMed ID: 26290369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furosemide and albumin for the treatment of nephrotic edema: a systematic review.
    Hedin E; Bijelić V; Barrowman N; Geier P
    Pediatr Nephrol; 2022 Aug; 37(8):1747-1757. PubMed ID: 35239032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ; Spencer AP; Eisele G
    Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium-sparing effect of amiloride in a diuretic factorial study in man.
    Schapel GJ; Edwards DG; Robinson J
    Clin Exp Pharmacol Physiol; 1975; 2(4):277-87. PubMed ID: 1097143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of combinations of diuretics in nephrotic edema.
    Garin EH
    Am J Dis Child; 1987 Jul; 141(7):769-71. PubMed ID: 3296741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Perspectives in Management of Edema in Nephrotic Syndrome.
    Meena J; Bagga A
    Indian J Pediatr; 2020 Aug; 87(8):633-640. PubMed ID: 32232733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome.
    Agarwal R; Gorski JC; Sundblad K; Brater DC
    J Am Soc Nephrol; 2000 Jun; 11(6):1100-1105. PubMed ID: 10820174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the combination of hydrochlorothiazide and amiloride (Moduretic) and furosemide in the treatment of cardiac edema].
    Hubert C; Sevens-Rocmans C; Demanet JC
    Acta Cardiol; 1973; 28(3):358-64. PubMed ID: 4543133
    [No Abstract]   [Full Text] [Related]  

  • 15. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
    Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
    Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.
    Kapur G; Valentini RP; Imam AA; Mattoo TK
    Clin J Am Soc Nephrol; 2009 May; 4(5):907-13. PubMed ID: 19406963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema.
    Tanaka M; Oida E; Nomura K; Nogaki F; Fukatsu A; Uemura K; Yashiro M; Kimura T; Muso E; Ono T
    Clin Exp Nephrol; 2005 Jun; 9(2):122-6. PubMed ID: 15980945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nephrotic edema with bumetanide.
    Lemieux G; Beauchemin M; Gougoux A; Vinay P
    Can Med Assoc J; 1981 Nov; 125(10):1111-2, 1117. PubMed ID: 7034916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide.
    Wang S; Pan Q; Xu C; Li JJ; Tang HX; Zou T; Jing KP; Ye L; Wu HL; Liu WJ; Liu HF
    Cell Physiol Biochem; 2018; 45(4):1700-1706. PubMed ID: 29490294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.